CSI Market
Sign In | Register

Takeda Pharmaceutical Limited (TAK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TAK Annual Balance Sheets →
From Takeda Pharmaceutical Limited through Mar 31 2024, shifts in Mar 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
0 0 0 (Mar 31 2024)
Assets
Cash And Cash Equivalents2,453.12
Current Tax Assets Current100.57
Cash & Short-term Investments2,553.00
Notes Receivable, Current447.69
Other Current Assets13,058.29
Total Current Assets16,059.67
Goodwill net33,915.94
Deferred Tax Assets2,361.60
Other Assets, Noncurrent38,422.93
Total Assets90,760.14
Liabilities
Longterm Borrowings25,264.99
Current Provisions3,396.03
Total Current Liabilities28,661.03
Long-term debt525.78
Total Long-term Debt525.78
Deferred Tax Liabilities, Net LI223.92
Noncurrent Provisions17,168.11
Total Liabilities46,578.84
Stockholders' Equity
Other Equity44,179.94
Common Stockholder's Equity44,179.94
Total Stockholder's Equity44,181.31
Liabilities & Stockholder's Equity90,760.14
4 historic quarters locked

Sign in to unlock the full Takeda Pharmaceutical Limited balance sheet history.

Sign In Create Free Account

About Takeda Pharmaceutical Co Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20260331)
  • Filed with the SEC: June 17, 2026
  • Source: tak-20260331.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001395064-26-000177

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.